Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.010 | 1 | 2011 | 2011 | ||||||
Deficiency of glucose-6-phosphate dehydrogenase
|
20 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.010 | 1 | 2009 | 2009 | ||||||
Diabetes
|
710 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.010 | 1 | 2009 | 2009 | ||||||
Diabetes Mellitus
|
824 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.010 | 1 | 2009 | 2009 | ||||||
Limb ischemia
|
3 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.010 | 1 | 2005 | 2005 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.010 | 1 | 2011 | 2011 | ||||||
PAI-1 4G/5G polymorphism
|
3 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.010 | 1 | 2011 | 2011 | ||||||
Pulmonary Thromboembolisms
|
6 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.010 | 1 | 2002 | 2002 | ||||||
Coronary Arteriosclerosis
|
440 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.020 | 0.500 | 2 | 2004 | 2009 | |||||
Coronary heart disease
|
1178 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.020 | 0.500 | 2 | 2004 | 2009 | |||||
Hypertensive disease
|
1085 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.020 | 0.500 | 2 | 2011 | 2014 | |||||
Lupus anticoagulant disorder
|
14 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.020 | 0.500 | 2 | 2005 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.020 | 0.500 | 2 | 1999 | 2015 | |||||
Methylenetetrahydrofolate reductase polymorphism
|
7 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.020 | 0.500 | 2 | 2009 | 2009 | |||||
Primary malignant neoplasm
|
1374 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.020 | 0.500 | 2 | 1999 | 2015 | |||||
Behcet Syndrome
|
243 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.030 | 0.667 | 3 | 2000 | 2013 | |||||
prothrombin gene mutation
|
5 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.030 | 0.667 | 3 | 2003 | 2012 | |||||
Coronary Artery Disease
|
1577 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.040 | 0.750 | 4 | 2000 | 2009 | |||||
Prothrombin G20210A mutation
|
9 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.040 | 0.750 | 4 | 2001 | 2008 | |||||
Ischemic stroke
|
704 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.090 | 0.778 | 9 | 2001 | 2013 | |||||
Activated Protein C Resistance
|
30 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.060 | 0.833 | 6 | 2002 | 2016 | |||||
Venous Thromboembolism
|
408 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.100 | 0.895 | 19 | 2000 | 2015 | |||||
Factor V Leiden mutation
|
46 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.100 | 0.912 | 34 | 1998 | 2019 | |||||
Thrombophilia
|
43 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.100 | 0.947 | 19 | 1999 | 2018 | |||||
Hyperhomocysteinemia
|
45 | 0.524 | 0.760 | 11 | 46725976 | missense variant | C/T | snv | 8.0E-06 | 0.100 | 1.000 | 13 | 1999 | 2016 |